Advertisement

Russian Journal of General Chemistry

, Volume 89, Issue 8, pp 1724–1727 | Cite as

N,N-Di(prop-2-yn-1-yl)adamantan-1-amines in 1,3-Dipolar Cycloaddition Reactions with Azide-Containing Pharmacophores

  • V. B. Sokolov
  • A. Yu. AksinenkoEmail author
Letters to the Editor
  • 8 Downloads

Abstract

A synthetic approach to combining pharmacophore ligands with an aminoadamantyl-containing spacer based on a copper-catalyzed alkyne-azide 1,3-dipolar cycloaddition of N,N-di(prop-2-yne-1-yl)adamantan-1-amines and azido-containing carbazole, tetrahydrocarbazole, phenothiazine and adamantan-2-amine derivatives was proposed.

Keywords

N,N-di(prop-2-yn-1-yl)adamantan-1-amines carbazole tetrahydrocarbazole phenothiazine adamantan-2-amine 1,3-dipolar cycloaddition 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Funding

This work was financially supported by the Russian Science Foundation (project no. 14-23-00160-P, synthesis of compounds 9–12) and the Ministry of Education and Science in the framework of the governmental task for 2018 (topic no. 0090-2017-0023).

References

  1. 1.
    Spilovska, K., Zemek, F., Korabecny, J., Nepovimova, E., Soukup, O., Windisch, M., and Kuca, K., Curr. Med. Chem., 2016, vol. 23, no. 29, p. 3245. doi  https://doi.org/10.2174/0929867323666160525114026 CrossRefGoogle Scholar
  2. 2.
    Crosby, N., Deane, K.H., and Clarke, C.E., Cochrane Database Syst. Rev., 2003, no. 1, Art. CD003468. doi  https://doi.org/10.1002/14651858.CD003468
  3. 3.
    Doody, R.S., Tariot, P.N., Pfeiffer, E., Olin, J.T., and Graham, S.M., Alzheimer’s Dement., 2007, vol. 3, no. 1, p. 7. doi  https://doi.org/10.1016/j.jalz.2006.10.004 CrossRefGoogle Scholar
  4. 4.
    Morozov, I.S., Klimova, N.V., and Lavrova, L.N., Pharm. Chem. J., 1998, vol. 32, no. 1, p. 3. doi  https://doi.org/10.1007/BF02464216 CrossRefGoogle Scholar
  5. 5.
    Bachurin, S.O., Bovina, E.V., and Ustyugov, A.A., Med. Res. Rev., 2017, vol. 37, no. 5, p. 1186. doi  https://doi.org/10.1002/med.21434 CrossRefGoogle Scholar
  6. 6.
    Bachurin, S.O., Gavrilova, S.I., Samsonova, A., Barreto, G.E., and Aliev, G., Pharmacol. Res., 2018, vol. 129, p. 216. doi  https://doi.org/10.1016/j.phrs.2017.11.021 CrossRefGoogle Scholar
  7. 7.
    MacMillan, K.S., Naidoo, J., Liang, J., Melito, L., Williams, N.S., Morlock, L., Huntington, P.J., Estill, S.J., Longgood, J., Becker, G.L., McKnight, S.L., Pieper, A.A., De Brabander, J.K., and Ready, J.M., J. Am. Chem. Soc., 2011, vol. 133, no. 5, p. 1428. doi  https://doi.org/10.1021/ja108211m CrossRefGoogle Scholar
  8. 8.
    Sokolov, V.B., Aksinenko, A.Yu., Goreva, T.V., Epishina, T.A., Grigor’ev, V.V., Gabrel’yan, A.V., Vinogradova, D.V., Dubova, L.G., Schevtsov, P.N., Schevtsova, E.F., and Bachurin, S.O., Russ. Chem. Bull., 2016, vol. 65, no. 5, p. 1346. doi  https://doi.org/10.1007/s11172-016-1460-6 CrossRefGoogle Scholar
  9. 9.
    Bandgar, B.P., Adsul, L.K., Chavan, H.V., Jalde, S.S., Shringare, S.N., Shaikh, R., Meshram, R.J., Nacche, G.R., and Masand, V, Bioorg. Med. Chem. Lett., 2012, vol. 22, no. 18, p. 5839. doi  https://doi.org/10.1016/j.bmcl.2012.07.080 CrossRefGoogle Scholar
  10. 10.
    Sokolov, V.B., Aksinenko, A.Yu., Epishina, T.A., and Goreva, T.V., Russ. Chem. Bull., 2018, vol. 67, no. 8, p. 1401. doi  https://doi.org/10.1007/s11172-018-2231-3 CrossRefGoogle Scholar
  11. 11.
    Rusu, R., Szumna, A., Rosu, N., Dumea, C., and Danac, R., Tetrahedron, 2015, vol. 71, no. 19, p. 2922. doi  https://doi.org/10.1016/j.tet.2015.03.060 CrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2019

Authors and Affiliations

  1. 1.Institute of Physiologically Active Substances of the Russian Academy of SciencesChernogolovkaRussia

Personalised recommendations